(Q77809280)

English

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

scientific article published on 01 October 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Y Sakata

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Ohtsu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

N Horikoshi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Sugimachi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Y Mitachi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T Taguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1715-1720

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Continuous 5-Fluorouracil Infusion in Advanced Gastric Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Report on nationwide pooled data and cohort investigation in UFT phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of combination therapy with 5'-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900211-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00211-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893658%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77809280&oldid=1741867087"